ARGX
argenx SE ADR · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Other
- Website argenx.com
- Employees(FY) 843
- ISIN US04016X1019
Performance
1W
1M
3M
6M
YTD
1Y
Profile
Investment Analysis Report: ARGX
Overview
ARGX is a pharmaceutical company operating in the Health Technology sector, specifically in the Pharmaceuticals: Other industry. The company has a market capitalization of $23.29 billion. In this report, we will conduct a comprehensive analysis of ARGX's financial health, earnings and revenue growth, pro...
Technical Analysis of ARGX 2024-07-18
Overview
The recent trading activity of ARGX presents a complex interplay of technical indicators that can provide insights into potential future price movements. By analyzing the trend, momentum, volatility, and volume indicators, we can form a comprehensive view of the stock's trajectory over the next few days.
Trend Indicators
-
Moving Avera...
Recent News & Updates
- 2024-07-25 20:30
Analyst Report: argenx SE(Morningstar Research)
- 2024-07-25 04:15
Argenx Swings to Q2 Profit, Total Operating Income Rises(MT Newswires)
- 2024-07-25 01:00
- 2024-07-24 13:00
- 2024-07-18 01:00
- 2024-07-17 13:00
- 2024-07-16 07:04
What Made argenx SE (ARGX) Rise in Q2?(Insider Monkey)
- 2024-07-16 04:38
- 2024-07-16 00:30
- 2024-07-16 00:30
- 2024-07-16 00:15
- 2024-07-16 00:15
- 2024-07-15 19:04
What Made argenx SE (ARGX) Rise in Q2?(Insidermonkey)
- 2024-06-26 09:04
Hidden Gems: Three Stocks Estimated Below Market Value in June 2024(Simply Wall St.)
- 2024-06-25 16:30
- 2024-06-25 04:30
- 2024-06-25 04:06
- 2024-06-24 16:11
Argenx Surges After Its Bread-And-Butter Drug Wins Another FDA Approval(Investor's Business Daily)
- 2024-06-24 12:23
Argenx Shares Rise Following Vyvgart Hytrulo Approval(MT Newswires)
- 2024-06-24 10:19
- 2024-06-24 06:53
FDA approves argenx’s VYVGART Hytrulo for CIDP treatment(Pharmaceutical Technology)
- 2024-06-24 05:15
Argenx soars on CIDP shot approval(Investing.com)
- 2024-06-24 04:46
- 2024-06-21 16:50
- 2024-06-21 04:50
- 2024-06-17 09:25
- 2024-06-17 01:00
- 2024-06-16 13:00
- 2024-06-06 18:37
Analyst Report: argenx SE(Morningstar Research)
- 2024-06-04 01:00